Because sIgA plays a more important role in mucosal immunity, especially for viral neutralization, a suitable vaccine should generate IgA-plasmablasts with many homing receptors to the mucosal surface to prevent person-to-person transmission, as in natural infection. The gene discussed is CD79A; the disease is infection.